- EQS-Adhoc: Carl Zeiss Meditec AG: Revenue and EBIT forecast for fiscal year 2023/24 reduced amid slower than expected recovery of equipment business
- EQS-News: Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects
- EQS-AFR: Carl Zeiss Meditec AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
Key statistics
On Monday, Carl Zeiss Meditec AG (0DHC:LSE) closed at 62.60, 3.05% above its 52-week low of 60.75, set on Jul 17, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 62.70 |
---|---|
High | 62.60 |
Low | 62.60 |
Bid | 60.75 |
Offer | 63.85 |
Previous close | 62.50 |
Average volume | 28.36k |
---|---|
Shares outstanding | 89.44m |
Free float | 36.55m |
P/E (TTM) | 21.41 |
Market cap | 5.61bn EUR |
EPS (TTM) | 2.93 EUR |
Annual div (ADY) | 1.10 EUR |
---|---|
Annual div yield (ADY) | 1.76% |
Div ex-date | Mar 22 2024 |
Div pay-date | Mar 26 2024 |
Data delayed at least 20 minutes, as of Jul 22 2024 17:19 BST.
More ▼